Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, August 21 2014 2:22am ET - U.S. Markets open in 7 hours and 8 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Thursday, Aug 21, 2014
·Illumina Partners With Big PharmaTo Create New Genetic Tests For Cancer
at - 22 minutes ago
Wednesday, Aug 20, 2014
·AstraZeneca Is Tougher Target for Possible New Pfizer Bid
at Bloomberg - Wed 7:00 pm ET
·Final Glance: Pharmaceuticals companies
AP - Wed 6:02 pm ET
·Sanofi's (SNY) Cerdelga FDA Approved for Gaucher Disease - Wed 5:30 pm ET
·Novartis to Invest $35M in Gamida Cell for 15% Equity - Wed 5:13 pm ET
·GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the US for the treatment of asthma
PR Newswire - Wed 3:33 pm ET
·Midday Glance: Pharmaceuticals companies
AP - Wed 1:50 pm ET
·3 Drugs Stocks Dragging The Industry Down
at - Wed 1:04 pm ET
·Early Glance: Pharmaceuticals companies
AP - Wed 12:22 pm ET
·Gilead Sciences: 'Risk of HCV Price War Overblown,' Bernstein Says
at - Wed 10:24 am ET
·[$$] Bristol-Myers, Celgene to Collaborate on Cancer-Treatment Study
at The Wall Street Journal Online - Wed 8:52 am ET
·Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014
Business Wire - Wed 8:00 am ET
·Bristol-Myers Squibb and Celgene Enter Clinical Collaboration Agreement to Evaluate Immunotherapy and Chemotherapy Combination Regimen
Business Wire - Wed 8:00 am ET
·North American Pharma-Biotech Sector to Wrap Up Construction on 157 Projects Worth $1.3 Billion in Third-Quarter 2014, an Industrial Info News Alert
Marketwire - Wed 6:15 am ET
·Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win
at - Wed 6:01 am ET
Tuesday, Aug 19, 2014
·Attention Impax Laboratories, Inc. Investors: Impax Misled Investors According to a Recently Filed Class Action
GlobeNewswire - Tue 7:42 pm ET
·US Department Of Justice Ends Investigation Of AstraZeneca Trial
at - Tue 7:24 pm ET
·U.S. FDA approves Sanofi's Gaucher disease drug Cerdelga
Reuters - Tue 5:29 pm ET
·FDA Approves Genzyme’s Cerdelga™ (eliglustat) Capsules
Business Wire - Tue 4:45 pm ET
·Pfizer Submits Palbociclib Marketing Application to the FDA - Tue 3:20 pm ET
More Latest News...
Sponsor Results
Medical Recalls Workshop
Learn About Recalls, Regulations & Procedures from FDA Experts
Prostate Cancer Treatment
Learn About Your Treatment Options. Our Free Guide & DVD Provides Facts
17.2% 2013 Annuity Return
True Investor Returns with no Risk. Find out how with our Free Report.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?